【Expert Insights on Life Sciences】Promising Prospects for Hong Kong Life Sciences

The pandemic has raised awareness from the public and investors towards the life sciences sector. Mr Vincent Cheung, Founder and Chairman of Hong Kong Life Sciences Society and CEO of Nan Fung Group, identified the competitive advantages of Hong Kong in driving life sciences forward.

About Mr Vincent Cheung

Vincent Cheung is currently the CEO of Nan Fung Group - an international business conglomerate with global interests in real estates, life sciences and financial investments. Vincent is also Chairman of Nan Fung Life Sciences (NFLS), a global investment platform focusing on life sciences, and he co-founded the biotech VC fund Pivotal bioVenture Partners with investment teams in both US and China. Under his leadership, NFLS has built significant presence across the industry (including therapeutics, medical devices and diagnostics) and all development stages.  His vision is to build NFLS to become the ideal partner for scientists, entrepreneurs, corporations and investors in the life sciences space.

Vincent is also the Founder and Chairman of Hong Kong Life Sciences Society, a youth organization aiming to build a dynamic life sciences ecosystem in Hong Kong with a focus of nurturing young talents. 

Vincent has been a member of The National Committee of the Chinese People’s Political Consultation Conference for Shanghai City since 2012, a Committee Member of the All-China Youth Federation since 2010, a Committee Member of All-China Financial Youth Federation and a Member of Shanghai Youth Federation.

Vincent graduated with high honours in Molecular and Cell Biology from University of California, Berkeley. While in Berkeley, he worked in Lawrence Berkeley National Laboratory as an independent researcher.